XERMELO
Total Payments
$258,513
Transactions
71
Doctors
46
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $9,281 | 1 | 1 |
| 2020 | $249,232 | 70 | 45 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $248,390 | 24 | 96.1% |
| Consulting Fee | $9,281 | 1 | 3.6% |
| Food and Beverage | $841.10 | 46 | 0.3% |
Payments by Type
Research
$248,390
24 transactions
General
$10,122
47 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Phase 2, Multicenter, open-label, safety and efficacy study of Xermelo (telotristat ethyl) plus first-line chemotherapy in patients with locally advanced, unresectable, recurrent or metastatic biliary tract cancer | TerSera Therapeutics LLC | $196,641 | 0 |
| Telotristate with Lutathera in NETs | TerSera Therapeutics LLC | $50,484 | 0 |
| Evaluation of Chemotherapy Effect on Serotonin Levels & Effect of Telotristat Treatment for Controlling Weight Loss in Patients with Advanced Stage Pancreatic Cancer | TerSera Therapeutics LLC | $1,265 | 0 |
Top Doctors Receiving Payments for XERMELO — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Internal Medicine | Huntersville, NC | $17.44 | 1 |
| , M.D | Hematology & Oncology | Bryn Mawr, PA | $16.26 | 1 |
| , MD | Hematology & Oncology | West Chester, PA | $16.26 | 1 |
| , M.D | Hematology & Oncology | Bryn Mawr, PA | $16.26 | 1 |
| , MD, MPH | Hematology & Oncology | Bryn Mawr, PA | $16.26 | 1 |
| , M.D | Medical Oncology | Athens, GA | $15.90 | 1 |
| , MD | Radiation Oncology | Pocatello, ID | $15.40 | 1 |
| , M.D | Hematology & Oncology | Idaho Falls, ID | $15.40 | 1 |
| , M.D | Otolaryngology/Facial Plastic Surgery | Lompoc, CA | $14.86 | 1 |
| , MD | Hematology & Oncology | Orange, CA | $14.86 | 1 |
| , MD | Hematology & Oncology | Orange, CA | $14.86 | 1 |
| , MD | Hematology & Oncology | Orange, CA | $14.86 | 1 |
| , MD | Internal Medicine | Santa Clara, CA | $14.86 | 1 |
| , M.D | Hematology & Oncology | Wichita, KS | $14.30 | 1 |
| , M.D | Hematology & Oncology | San Diego, CA | $13.76 | 1 |
| , MD | Hematology & Oncology | Wichita, KS | $13.48 | 1 |
| , MD | Hematology & Oncology | Sumter, SC | $12.06 | 1 |
| , MD | Hematology | Trinity, FL | $11.95 | 1 |
| , M.D | Hematology | Hudson, FL | $11.95 | 1 |
| , M.D | Hematology | New Port Richey, FL | $11.95 | 1 |
| , M.D | Internal Medicine | New Port Richey, FL | $11.95 | 1 |
| , M.D | Radiation Oncology | Lady Lake, FL | $11.86 | 1 |
Ad
Manufacturing Companies
- TerSera Therapeutics LLC $258,513
Product Information
- Type Drug
- Total Payments $258,513
- Total Doctors 46
- Transactions 71
About XERMELO
XERMELO is a drug associated with $258,513 in payments to 46 healthcare providers, recorded across 71 transactions in the CMS Open Payments database. The primary manufacturer is TerSera Therapeutics LLC.
Payment data is available from 2020 to 2021. In 2021, $9,281 was paid across 1 transactions to 1 doctors.
The most common payment nature for XERMELO is "Unspecified" ($248,390, 96.1% of total).
XERMELO is associated with 3 research studies, including "A Phase 2, Multicenter, open-label, safety and efficacy study of Xermelo (telotristat ethyl) plus first-line chemotherapy in patients with locally advanced, unresectable, recurrent or metastatic biliary tract cancer" ($196,641).